
The
company's
exclusive focus is the
successful development
of technologies for the groundbreaking treatment of central nervous system traumatic injuries.
Our goal
is
to develop![]()
and commercialize
nervous
system![]()
injury corrective therapeutics. Our success will establish our company as a premier firm in the
field of biomarkers monitoring.
Site Under Construction